Supplements
Low effectiveness score reflects promising animal data (e.g., wound healing in mice at various doses, PMID:10469335) but absence of robust human RCTs for recovery claims; Phase I only confirms PK/safety, not efficacy (PMID:34346165). Safety penalized for FDA Category 2 status prohibiting use (bscg.org/blogs/single/tb-500-status-risks-and-bans), high-dose discrepancy (clinical μg/kg vs user mg/week), and contamination risks in unregulated peptides. Quality low absent independent testing; Reddit a
Avoid TB-500 due to lack of FDA approval, limited human evidence beyond safety at low doses, and significant risks from unregulated sourcing. Safer evidence-based options like physical therapy or approved meds preferred for recovery. Consult physician before use.